DiaMedica Therapeutics (DMAC) Assets Average (2019 - 2026)
DiaMedica Therapeutics (DMAC) posted quarterly Assets Average of $57.2 million for Q1 2026, up 34.37% year-over-year from $42.6 million in Q1 2025, and down 3.35% quarter-over-quarter from $59.2 million in Q4 2025.
DiaMedica Therapeutics (DMAC) Assets Average (2019 - 2026) Analysis & Trends
DiaMedica Therapeutics' Assets Average history runs 8 years deep, the most recent figure standing at $57.2 million for Q1 2026.
- In Q1 2026, Assets Average rose 34.37% year-over-year to $57.2 million; the TTM figure through Mar 2026 stood at $57.2 million (up 34.37% YoY), while the FY2025 annual figure was $53.9 million, up 7.17% from the prior year.
- Assets Average for Q1 2026 stood at $57.2 million, down from $59.2 million in the prior quarter.
- The five-year high for Assets Average was $60.1 million in Q3 2023, with the low at $32.3 million in Q1 2023.
- The 5-year median for Assets Average is $46.1 million (2023), against an average of $47.1 million.
- The sharpest annual moves came in 2022 and 2025: Assets Average soared 76.61% in 2022, then slumped 33.71% in 2025.
- DiaMedica Therapeutics' Assets Average stood at $35.7 million in 2022, then surged by 57.2% to $56.1 million in 2023, then retreated by 11.96% to $49.4 million in 2024, then rose by 19.77% to $59.2 million in 2025, then slipped by 3.35% to $57.2 million in 2026.
- Business Quant data shows DMAC's Assets Average at $57.2 million in Q1 2026, $59.2 million in Q4 2025, and $44.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | DiaMedica Therapeutics | 360.22 Mn | 360.22 Mn | - | 49.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 49.04 Mn |
| Mar 31, 2026 | 57.23 Mn |
| Dec 31, 2025 | 59.21 Mn |
| Sep 30, 2025 | 44.26 Mn |
| Jun 30, 2025 | 35.15 Mn |
| Mar 31, 2025 | 42.59 Mn |
| Dec 31, 2024 | 49.43 Mn |
| Sep 30, 2024 | 54.66 Mn |
| Jun 30, 2024 | 53.03 Mn |
| Mar 31, 2024 | 51.71 Mn |
| Dec 31, 2023 | 56.15 Mn |
| Sep 30, 2023 | 60.09 Mn |
| Jun 30, 2023 | 46.13 Mn |
| Mar 31, 2023 | 32.31 Mn |
| Dec 31, 2022 | 35.72 Mn |
| Sep 30, 2022 | 38.15 Mn |
| Jun 30, 2022 | 40.73 Mn |
| Mar 31, 2022 | 43.88 Mn |
| Dec 31, 2021 | 47.11 Mn |
| Sep 30, 2021 | 35.22 Mn |